| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Spectroscopy | 35 | 2018 | 3757 | 2.980 |
Why?
|
| Pseudomonas aeruginosa | 9 | 2024 | 1275 | 1.750 |
Why?
|
| Muscle, Skeletal | 17 | 2024 | 4901 | 1.640 |
Why?
|
| Pseudomonas Infections | 8 | 2024 | 621 | 1.340 |
Why?
|
| Burns | 10 | 2013 | 1849 | 1.310 |
Why?
|
| Brain Neoplasms | 20 | 2016 | 8981 | 1.040 |
Why?
|
| Acetophenones | 3 | 2024 | 52 | 1.030 |
Why?
|
| Robotics | 5 | 2019 | 819 | 1.000 |
Why?
|
| Quorum Sensing | 6 | 2024 | 137 | 0.850 |
Why?
|
| Adenosine Triphosphate | 8 | 2024 | 1986 | 0.830 |
Why?
|
| Magnetic Resonance Imaging | 24 | 2023 | 36270 | 0.820 |
Why?
|
| Mitochondria | 11 | 2024 | 3583 | 0.810 |
Why?
|
| Drosophila melanogaster | 4 | 2015 | 1708 | 0.680 |
Why?
|
| Ion Channels | 3 | 2015 | 1043 | 0.620 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 976 | 0.570 |
Why?
|
| Volatile Organic Compounds | 1 | 2018 | 84 | 0.570 |
Why?
|
| Hand Strength | 2 | 2019 | 452 | 0.560 |
Why?
|
| Insulin Resistance | 4 | 2015 | 3941 | 0.560 |
Why?
|
| Lipid Metabolism | 9 | 2010 | 1895 | 0.520 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2009 | 509 | 0.500 |
Why?
|
| Citric Acid Cycle | 2 | 2013 | 230 | 0.500 |
Why?
|
| Contrast Media | 4 | 2018 | 5297 | 0.490 |
Why?
|
| Neuronal Plasticity | 3 | 2013 | 1429 | 0.480 |
Why?
|
| Stroke | 5 | 2023 | 9695 | 0.460 |
Why?
|
| Mitochondria, Muscle | 2 | 2024 | 172 | 0.450 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 1475 | 0.430 |
Why?
|
| Thoracic Injuries | 1 | 2015 | 280 | 0.430 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 2056 | 0.430 |
Why?
|
| Drosophila Proteins | 2 | 2014 | 1698 | 0.420 |
Why?
|
| Cachexia | 2 | 2013 | 197 | 0.420 |
Why?
|
| Oligopeptides | 3 | 2024 | 1184 | 0.410 |
Why?
|
| Glutathione Transferase | 1 | 2014 | 564 | 0.400 |
Why?
|
| Apoptosis | 5 | 2016 | 9466 | 0.360 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 2475 | 0.360 |
Why?
|
| Gene Expression Profiling | 8 | 2012 | 9403 | 0.360 |
Why?
|
| Mitochondrial Diseases | 1 | 2013 | 340 | 0.340 |
Why?
|
| Magnetite Nanoparticles | 1 | 2010 | 315 | 0.320 |
Why?
|
| Dextrans | 1 | 2010 | 573 | 0.310 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3774 | 0.310 |
Why?
|
| Wound Infection | 1 | 2010 | 243 | 0.310 |
Why?
|
| Aspartic Acid | 5 | 2004 | 576 | 0.300 |
Why?
|
| Image Enhancement | 1 | 2018 | 2880 | 0.300 |
Why?
|
| Glycine | 2 | 2010 | 662 | 0.300 |
Why?
|
| Oxidative Stress | 2 | 2016 | 3102 | 0.290 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1442 | 0.290 |
Why?
|
| Antioxidants | 2 | 2019 | 1665 | 0.270 |
Why?
|
| Lipids | 4 | 2014 | 3326 | 0.240 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2015 | 162 | 0.240 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2008 | 1491 | 0.230 |
Why?
|
| Choline | 8 | 2004 | 513 | 0.230 |
Why?
|
| Energy Metabolism | 2 | 2024 | 2867 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 8946 | 0.220 |
Why?
|
| Genomics | 2 | 2010 | 5788 | 0.210 |
Why?
|
| Protons | 5 | 2008 | 1112 | 0.210 |
Why?
|
| Macrophages | 2 | 2024 | 5732 | 0.210 |
Why?
|
| Mice | 18 | 2024 | 81066 | 0.210 |
Why?
|
| Paresis | 1 | 2023 | 176 | 0.200 |
Why?
|
| Brain | 11 | 2013 | 26952 | 0.200 |
Why?
|
| Animals | 23 | 2024 | 167718 | 0.200 |
Why?
|
| Asphyxia Neonatorum | 1 | 2002 | 111 | 0.200 |
Why?
|
| Hindlimb | 4 | 2008 | 508 | 0.190 |
Why?
|
| Trans-Activators | 2 | 2008 | 2859 | 0.190 |
Why?
|
| Gadolinium DTPA | 2 | 2002 | 823 | 0.190 |
Why?
|
| Hand | 3 | 2019 | 902 | 0.180 |
Why?
|
| Biopsy | 6 | 2016 | 6757 | 0.180 |
Why?
|
| Artificial Intelligence | 2 | 2012 | 2548 | 0.180 |
Why?
|
| Down-Regulation | 1 | 2008 | 2901 | 0.180 |
Why?
|
| Blood Volume | 1 | 2002 | 548 | 0.180 |
Why?
|
| Lactic Acid | 3 | 2004 | 1133 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2007 | 916 | 0.170 |
Why?
|
| Glioblastoma | 3 | 2012 | 3480 | 0.170 |
Why?
|
| Insulin | 2 | 2014 | 6578 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 2 | 2002 | 2725 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 3 | 2024 | 495 | 0.170 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2004 | 1431 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 4886 | 0.160 |
Why?
|
| Motor Activity | 1 | 2009 | 2685 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 8503 | 0.160 |
Why?
|
| Mice, Inbred Strains | 3 | 2010 | 1758 | 0.150 |
Why?
|
| Body Surface Area | 2 | 2008 | 197 | 0.150 |
Why?
|
| Brain Chemistry | 4 | 2004 | 959 | 0.150 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2010 | 553 | 0.140 |
Why?
|
| Speech Perception | 1 | 2002 | 505 | 0.140 |
Why?
|
| Spin Labels | 2 | 2008 | 336 | 0.140 |
Why?
|
| Aging | 1 | 2015 | 8654 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 2 | 2009 | 262 | 0.140 |
Why?
|
| Humans | 42 | 2024 | 757566 | 0.140 |
Why?
|
| Arousal | 1 | 2002 | 1157 | 0.130 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 2127 | 0.130 |
Why?
|
| Neoplasm Staging | 2 | 2008 | 11082 | 0.130 |
Why?
|
| Algorithms | 4 | 2009 | 13952 | 0.130 |
Why?
|
| Metabolome | 2 | 2014 | 982 | 0.130 |
Why?
|
| Child | 17 | 2016 | 79782 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 293 | 0.120 |
Why?
|
| Glioma | 3 | 2012 | 3417 | 0.120 |
Why?
|
| Male | 30 | 2024 | 358180 | 0.120 |
Why?
|
| Moyamoya Disease | 1 | 1997 | 256 | 0.110 |
Why?
|
| Cerebellum | 2 | 2013 | 1497 | 0.110 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 11890 | 0.110 |
Why?
|
| Tetrazolium Salts | 1 | 2013 | 92 | 0.110 |
Why?
|
| Amino Acids | 2 | 2010 | 1712 | 0.110 |
Why?
|
| Inositol | 2 | 2010 | 215 | 0.110 |
Why?
|
| Motor Cortex | 2 | 2013 | 997 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 1878 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2013 | 2223 | 0.110 |
Why?
|
| Aconitate Hydratase | 1 | 2013 | 16 | 0.110 |
Why?
|
| Transcription Factors | 6 | 2024 | 12092 | 0.110 |
Why?
|
| Neoplasms | 2 | 2013 | 21986 | 0.110 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 364 | 0.100 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.100 |
Why?
|
| RNA, Messenger | 4 | 2009 | 12761 | 0.100 |
Why?
|
| Mutation | 2 | 2014 | 29929 | 0.100 |
Why?
|
| Child, Preschool | 11 | 2009 | 42045 | 0.100 |
Why?
|
| Infant | 10 | 2009 | 36045 | 0.100 |
Why?
|
| Attention | 1 | 2002 | 2387 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 695 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2014 | 23335 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2019 | 540 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6230 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 3824 | 0.090 |
Why?
|
| Reference Values | 2 | 2012 | 4918 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2013 | 745 | 0.090 |
Why?
|
| Adolescent | 12 | 2010 | 87819 | 0.090 |
Why?
|
| Receptors, Glucagon | 1 | 2010 | 90 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2006 | 7927 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18114 | 0.090 |
Why?
|
| Glutarates | 1 | 2012 | 243 | 0.090 |
Why?
|
| Nerve Net | 1 | 2002 | 2264 | 0.090 |
Why?
|
| PPAR delta | 1 | 2009 | 40 | 0.080 |
Why?
|
| Equipment and Supplies | 1 | 2012 | 273 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1293 | 0.080 |
Why?
|
| Central Nervous System Diseases | 1 | 1993 | 519 | 0.080 |
Why?
|
| Random Allocation | 2 | 2010 | 2388 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2009 | 175 | 0.080 |
Why?
|
| Phosphorus Isotopes | 1 | 2008 | 124 | 0.080 |
Why?
|
| Fatty Acids | 2 | 2006 | 1803 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2008 | 6337 | 0.070 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2008 | 240 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 21990 | 0.070 |
Why?
|
| Muscular Atrophy | 1 | 2010 | 327 | 0.070 |
Why?
|
| Astrocytoma | 1 | 2012 | 775 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2013 | 9263 | 0.070 |
Why?
|
| Ischemia | 1 | 2016 | 1863 | 0.070 |
Why?
|
| Prognosis | 4 | 2011 | 29488 | 0.070 |
Why?
|
| Models, Biological | 3 | 2008 | 9459 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2014 | 1054 | 0.070 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 2013 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 7399 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 392 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2010 | 557 | 0.070 |
Why?
|
| Logistic Models | 3 | 2011 | 13221 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2014 | 1044 | 0.070 |
Why?
|
| Artificial Limbs | 1 | 2008 | 121 | 0.070 |
Why?
|
| Thiazoles | 1 | 2013 | 1511 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2013 | 5031 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 5756 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 20037 | 0.060 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2012 | 928 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 795 | 0.060 |
Why?
|
| Phantoms, Imaging | 2 | 2012 | 2509 | 0.060 |
Why?
|
| Electron Transport | 1 | 2005 | 205 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 609 | 0.060 |
Why?
|
| Metabolomics | 1 | 2013 | 1629 | 0.060 |
Why?
|
| Glycolysis | 1 | 2008 | 826 | 0.060 |
Why?
|
| Gluconeogenesis | 1 | 2005 | 185 | 0.060 |
Why?
|
| Radiography | 2 | 2013 | 6956 | 0.060 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2003 | 46 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 7588 | 0.050 |
Why?
|
| Meningioma | 1 | 2012 | 1217 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2006 | 780 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2013 | 2969 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2009 | 1419 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 14637 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 13263 | 0.050 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2001 | 38 | 0.050 |
Why?
|
| Phosphates | 1 | 2005 | 771 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 620 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2008 | 2105 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2009 | 1757 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 623 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2024 | 511 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 1896 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2007 | 2696 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 2496 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 820 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2868 | 0.040 |
Why?
|
| Diffusion | 1 | 2002 | 812 | 0.040 |
Why?
|
| Age Factors | 2 | 2010 | 18326 | 0.040 |
Why?
|
| Epilepsy | 2 | 2012 | 3270 | 0.040 |
Why?
|
| Creatine | 2 | 2004 | 426 | 0.040 |
Why?
|
| Female | 14 | 2012 | 389943 | 0.040 |
Why?
|
| Xanthine Oxidase | 1 | 2019 | 69 | 0.040 |
Why?
|
| Lactates | 2 | 2000 | 404 | 0.040 |
Why?
|
| Adult | 10 | 2012 | 219725 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 222 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2019 | 261 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2011 | 10075 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2009 | 3040 | 0.040 |
Why?
|
| Wakefulness | 1 | 2005 | 1256 | 0.040 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2001 | 352 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 2891 | 0.040 |
Why?
|
| Virulence | 2 | 2014 | 1298 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2011 | 6198 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2002 | 1005 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5194 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2024 | 2208 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2009 | 4937 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 6204 | 0.030 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 101 | 0.030 |
Why?
|
| Disease Progression | 2 | 2004 | 13463 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2024 | 2295 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2000 | 849 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6323 | 0.030 |
Why?
|
| Young Adult | 3 | 2012 | 58755 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22022 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 1150 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 12870 | 0.030 |
Why?
|
| Gene Expression | 1 | 2006 | 7584 | 0.030 |
Why?
|
| Drug Resistance, Multiple | 1 | 2014 | 253 | 0.030 |
Why?
|
| Capillaries | 1 | 2016 | 744 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1065 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 12397 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 25924 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 869 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 856 | 0.020 |
Why?
|
| Middle Aged | 4 | 2012 | 219192 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2001 | 1494 | 0.020 |
Why?
|
| Extremities | 1 | 2016 | 865 | 0.020 |
Why?
|
| Creatinine | 1 | 1996 | 1892 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 15207 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1477 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2003 | 26176 | 0.020 |
Why?
|
| Virus Cultivation | 1 | 2007 | 88 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 39811 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1997 | 4156 | 0.020 |
Why?
|
| Rheology | 1 | 2008 | 348 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2002 | 6571 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1993 | 1332 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 8296 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2019 | 18936 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 9245 | 0.010 |
Why?
|
| Hydrogen | 1 | 2003 | 171 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1993 | 2650 | 0.010 |
Why?
|
| Quinolines | 1 | 2007 | 758 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2007 | 1131 | 0.010 |
Why?
|
| Cytokines | 1 | 2016 | 7336 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 64242 | 0.010 |
Why?
|
| Phosphorylcholine | 1 | 2000 | 153 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 1976 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2001 | 469 | 0.010 |
Why?
|
| Gliosis | 1 | 2000 | 244 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2001 | 553 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5856 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 5781 | 0.010 |
Why?
|
| Resuscitation | 1 | 2001 | 661 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 1828 | 0.010 |
Why?
|
| Brain Stem | 1 | 2001 | 857 | 0.010 |
Why?
|
| Necrosis | 1 | 2000 | 1604 | 0.010 |
Why?
|
| Thalamus | 1 | 2001 | 1040 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 2901 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 10709 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15781 | 0.000 |
Why?
|
| Aged | 1 | 2012 | 167890 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2003 | 79984 | 0.000 |
Why?
|